Results 221 to 230 of about 39,467 (264)

Ocular manifestations in leukemia and myeloproliferative disorders and their association with hematological parameters.

Ann Afr Med, 2016
Dhasmana R, Prakash A, Gupta N, Verma SK.   +3 more
europepmc   +1 more source

Cerebral venous sinus thrombosis with head trauma and myeloproliferative neoplasm-unclassifiable: A case report. [PDF]

Medicine (Baltimore)
Chu Q, Chu Q, Zhou Z, Zhou H, Xu Z, Xu P, Xu Z.   +6 more
europepmc   +1 more source

Janus kinase 2 mutations in cases with BCR-ABL-negative chronic myeloproliferative disorders from Turkey.

Avicenna J Med, 2017
Yildiz I, Yokuş O, Gedik H.
europepmc   +1 more source

Developing a Framework of Entrustable Professional Activities for Residency Training in Hematology. [PDF]

Adv Med Educ Pract
Tian H, Xu L, Xi J, Yin J, Dai H, Wang Y, Chen J, Li C, Zhu Y, Wang H, Zhou M, Long Y, Song X, Yang L, Qi J, Zhou J, Xue S.   +16 more
europepmc   +1 more source

An acquired translocation in JAK2 Val617Phe-negative essential thrombocythemia associated with autosomal spread of X-inactivation [PDF]

, 2006
Baxter, E. Joanna, Campbell, Peter J., Culligan, Dominic A., Fourouclas, Nasios, Green, Anthony R., Huntly, Brian J. P., Li, Juan, Munro, Laura R., Roberts, Ian, Scott, Linda M., Swanton, Soheila, Vassiliou, George S.   +11 more
core  

Trombose Venosa Esplâncnica: Factores de Risco [PDF]

, 2012
Tiago Alexandre Espada Guerreiro
core  

Pre-existing oncohematological disease in kidney transplant recipients: impact on graft survival, acute rejection, and long-term clinical outcomes. [PDF]

Front Immunol
Mella A, Clari R, Deiana V, Giraudi R, Giovinazzo G, Gallo E, Dolla C, Lavacca A, Manzione AM, Fop F, Allesina A, Cavallo F, Bringhen S, Ferrero D, Mina R, Tarella C, Bruno B, Mariano F, Biancone L.   +18 more
europepmc   +1 more source

Latent JAK2 V617F-Positive Myeloproliferative Neoplasm With Normal Blood Counts and Recurrent Splanchnic Vein Thrombosis in a Young Woman. [PDF]

Cureus
Thida AM, Luhrs C, Baral A, Zhonghua L, Brown J.   +4 more
europepmc   +1 more source